C
Citius Oncology Inc
NASDAQ:CTOR
Citius Oncology Inc
NASDAQ:CTOR
Price:
0.66
USD
2.77%
Market Closed
Market Cap:
$58.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
Bellring Brands Inc
NYSE:BRBR
|
US |
|
Tata Technologies Ltd
NSE:TATATECH
|
IN |
|
Columbia Financial Inc
NASDAQ:CLBK
|
US |
|
U
|
UL Solutions Inc
NYSE:ULS
|
US |
|
M
|
Mega Study Co Ltd
KOSDAQ:072870
|
KR |
|
P
|
Phuong Nam Education Investment and Development JSC
VN:SED
|
VN |
|
Beijing Global Safety Technology Co Ltd
SZSE:300523
|
CN |
|
Super League Enterprise Inc
NASDAQ:SLE
|
US |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
Youngone Corp
KRX:111770
|
KR |
|
K W Nelson Interior Design and Contracting Group Ltd
HKEX:8411
|
HK |
|
W
|
Waps Co Ltd
KOSDAQ:196700
|
KR |
|
Avanti Feeds Ltd
NSE:AVANTIFEED
|
IN |
|
Goltas Goller Bolgesi Cimento Sanayi ve Ticaret AS
IST:GOLTS.E
|
TR |
Balance Sheet
Balance Sheet Decomposition
Citius Oncology Inc
Citius Oncology Inc
Balance Sheet Decomposition is not available for
Citius Oncology Inc
Citius Oncology Inc
Balance Sheet
Citius Oncology Inc
Citius Oncology Inc
Currency: USD
| Sep-2024 | Sep-2025 | ||
|---|---|---|---|
| Assets | |||
| Cash & Cash Equivalents |
0
|
4
|
|
| Cash Equivalents |
0
|
4
|
|
| Inventory |
8
|
22
|
|
| Other Current Assets |
3
|
1
|
|
| Total Current Assets |
11
|
28
|
|
| Intangible Assets |
73
|
73
|
|
| Total Assets |
84
N/A
|
101
+20%
|
|
| Liabilities | |||
| Accounts Payable |
4
|
13
|
|
| Accrued Liabilities |
0
|
4
|
|
| Short-Term Debt |
0
|
0
|
|
| Other Current Liabilities |
29
|
32
|
|
| Total Current Liabilities |
33
|
49
|
|
| Long-Term Debt |
4
|
4
|
|
| Deferred Income Tax |
2
|
3
|
|
| Other Liabilities |
0
|
0
|
|
| Total Liabilities |
38
N/A
|
56
+47%
|
|
| Equity | |||
| Common Stock |
0
|
0
|
|
| Retained Earnings |
39
|
64
|
|
| Additional Paid In Capital |
85
|
109
|
|
| Total Equity |
46
N/A
|
45
-3%
|
|
| Total Liabilities & Equity |
84
N/A
|
101
+20%
|
|
| Shares Outstanding | |||
| Common Shares Outstanding |
72
|
84
|
|
Switch to:
Switch to:
See Also
Discover More
